Agilent Genomics is part of Agilent’s fourth and newest business, Diagnostics and Genomics Division. DGG is headed by Lars Holmkvist, who reports to the Agilent President and CEO Bill Sullivan, and has approximately 1,695 employees in total. The focus of DGG is on cancer diagnostics, cytogenetics research and genomics tools for molecular analysis.
Focus on developing new technologies in the field of genomics.
Role within Neuromics
Responsible for the development and supply of the Neuromics project with reagent kits for targeted re-sequencing.
Workpackage 5 - Development and implementation of disease group overlapping NGS-based diagnostic panels